215 related articles for article (PubMed ID: 3306531)
1. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
Bartram CR
Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
[TBL] [Abstract][Full Text] [Related]
2. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
[TBL] [Abstract][Full Text] [Related]
3. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
[TBL] [Abstract][Full Text] [Related]
4. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
[TBL] [Abstract][Full Text] [Related]
5. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
[TBL] [Abstract][Full Text] [Related]
6. Chromosome abnormalities in CML.
Hagemeijer A
Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
[TBL] [Abstract][Full Text] [Related]
7. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.
Kurzrock R; Shtalrid M; Talpaz M; Kloetzer WS; Gutterman JU
Blood; 1987 Nov; 70(5):1584-8. PubMed ID: 3311207
[TBL] [Abstract][Full Text] [Related]
9. Structural organization of the bcr gene and its role in the Ph' translocation.
Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology of chronic myeloid leukemia].
Hellmann A
Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
[TBL] [Abstract][Full Text] [Related]
11. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
12. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
13. [BCR and ABL gene rearrangement in chronic myeloid leukemia].
Rypácková B; Haskovec C; Brdicka R
Vnitr Lek; 1993 Oct; 39(10):964-8. PubMed ID: 8236869
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of bcr and c-abl sequences in Ph-positive acute leukemias and Ph-negative CML--an update.
Bartram CR
Haematol Blood Transfus; 1987; 31():160-2. PubMed ID: 3481751
[No Abstract] [Full Text] [Related]
15. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
16. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
17. Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.
De Klein A
Mutat Res; 1987 Sep; 186(2):161-72. PubMed ID: 3306360
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
19. Lack of reciprocal translocation in BCR-ABL positive Ph-negative chronic myeloid leukaemia.
Lazaridou A; Chase A; Melo J; Garicochea B; Diamond J; Goldman J
Leukemia; 1994 Mar; 8(3):454-7. PubMed ID: 8127150
[TBL] [Abstract][Full Text] [Related]
20. The molecular pathology of chronic myelogenous leukaemia.
Kurzrock R; Talpaz M
Br J Haematol; 1991 Oct; 79 Suppl 1():34-7. PubMed ID: 1931706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
